| The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells T Gotoh, M Vila-Caballer, CS Santos, J Liu, J Yang, CV Finkielstein Molecular biology of the cell 25 (19), 3081-3093, 2014 | 108 | 2014 |
| Chronotherapy: intuitive, sound, founded… but not broadly applied JM Selfridge, T Gotoh, S Schiffhauer, JJ Liu, PE Stauffer, A Li, ... Drugs 76, 1507-1521, 2016 | 89 | 2016 |
| Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia Y Gocho, J Liu, J Hu, W Yang, NV Dharia, J Zhang, H Shi, G Du, A John, ... Nature cancer 2 (3), 284-299, 2021 | 86 | 2021 |
| Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2 T Gotoh, JK Kim, J Liu, M Vila-Caballer, PE Stauffer, JJ Tyson, ... Proceedings of the National Academy of Sciences 113 (47), 13516-13521, 2016 | 86 | 2016 |
| Association of the circadian factor Period 2 to p53 influences p53's function in DNA-damage signaling T Gotoh, M Vila-Caballer, J Liu, S Schiffhauer, CV Finkielstein Molecular biology of the cell 26 (2), 359-372, 2015 | 65 | 2015 |
| Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia RJ Autry, SW Paugh, R Carter, L Shi, J Liu, DC Ferguson, CE Lau, ... Nature cancer 1 (3), 329-344, 2020 | 51 | 2020 |
| Distinct control of PERIOD2 degradation and circadian rhythms by the oncoprotein and ubiquitin ligase MDM2 JJ Liu, X Zou, T Gotoh, AM Brown, L Jiang, EL Wisdom, JK Kim, ... Science Signaling 11 (556), eaau0715, 2018 | 41 | 2018 |
| A systems biology approach identifies hidden regulatory connections between the circadian and cell-cycle checkpoints X Zou, DW Kim, T Gotoh, J Liu, JK Kim, CV Finkielstein Frontiers in Physiology 11, 532355, 2020 | 20 | 2020 |
| Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination V Tosello, D Bongiovanni, J Liu, Q Pan, K Yan, V Saccomani, ... Leukemia 35 (4), 984-1000, 2021 | 13 | 2021 |
| Tailoring chemotherapy for the African-centric S47 variant of TP53 T Barnoud, A Budina-Kolomets, S Basu, JIJ Leu, M Good, CP Kung, J Liu, ... Cancer research 78 (19), 5694-5705, 2018 | 13 | 2018 |
| Ligand binding reveals a role for heme in translationally-controlled tumor protein dimerization AT Lucas, X Fu, JJ Liu, MK Brannon, J Yang, DGS Capelluto, ... PLoS One 9 (11), e112823, 2014 | 11 | 2014 |
| An ABC transporter drives medulloblastoma pathogenesis by regulating sonic hedgehog signaling J Wijaya, BHT Vo, J Liu, B Xu, G Wu, Y Wang, J Peng, J Zhang, LJ Janke, ... Cancer Research 80 (7), 1524-1537, 2020 | 9 | 2020 |
| Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma A Pribnow, B Jonchere, J Liu, KS Smith, O Campagne, K Xu, S Robinson, ... Molecular cancer therapeutics 21 (8), 1306-1317, 2022 | 3 | 2022 |
